Psyence Biomedical Ltd.
NASDAQ: PBM
Healthcare
Biotechnology
Rank
#44510
Market Cap
2.71 M
Volume
213,554
Price
4.77
Change (%)
37.94%
Country or region
Canada
Canada
Psyence Biomedical Ltd. Stock Split History Overview
This company has undergone a total of two stock splits throughout its history. Two reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 5, 2025 with a ratio of 1-for-7.97. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Psyence Biomedical Ltd. (NASDAQ: PBM) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 5, 2025 | 1:7.97 | x0.12547052 | x0.0016724943 | Reverse |
| November 26, 2024 | 1:75.02 | x0.01332978 | x0.01332978 | Reverse |
Frequently Asked Questions
If Psyence Biomedical Ltd. (stock symbol: NASDAQ: PBM) had never undergone any stock splits, its price per share today would be approximately 0.01 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-7.97) that occurred on May 5, 2025.
Psyence Biomedical Ltd. (stock symbol: NASDAQ: PBM) has undergone a total of two stock splits. The most recent split occurred on May 5, 2025. One share bought prior to the first split on November 26, 2024 would now equal 0.00 shares.
Psyence Biomedical Ltd. (stock symbol: NASDAQ: PBM) has undergone 2 stock splits in its history. The most recent split, a 1-for-75.02 split, occurred on May 5, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.